Group 1 - Eric Sprott announced the expiration of 1,950,000 common share purchase warrants of Unigold Inc., which represents a decrease in holdings of approximately 10% of the outstanding common shares on a partially diluted basis [1][2] - Prior to the expiration, Mr. Sprott beneficially owned and controlled 22,400,000 shares, representing approximately 8.0% of the outstanding shares on a non-diluted basis and approximately 8.6% on a partially diluted basis [1] - Following the expiration of the warrants and new share issuances by Unigold, Mr. Sprott's ownership decreased to under 10% on a non-diluted basis, resulting in him and 2176423 Ontario Ltd. ceasing to be insiders of Unigold [2] Group 2 - The securities held by Mr. Sprott are for investment purposes, with a long-term view, and he may acquire additional securities or sell existing ones depending on market conditions and other relevant factors [3]

Nova Pacific Drills 16.2m @ 3.2 g/t AuEq and 17.64m @ 1.92 g/t AuEq from First Assay Results at Lara VMS Project on Vancouver Island, B.C. June 24, 2025 8:30 AM EDT | Source: Nova Pacific Metals Corp. Vancouver, British Columbia--(Newsfile Corp. - June 24, 2025) - Nova Pacific Metals Corp. (CSE: NVPC) (OTCQB: NVPCF) (FSE: YQ10) (WKN: A40GFH) ("Nova Pacific" or the "Company") is pleased to report assays from the first four holes, totaling 582 metres ("m"), of its ongoing 8,700-m exploration drilling campaign ...

Vancouver, British Columbia--(Newsfile Corp. - June 24, 2025) - Vizsla Royalties Corp. (TSXV: VROY) (OTCQB: VROYF) ("Vizsla Royalties" or the "Company") congratulates Vizsla Silver Corp. ("Vizsla Silver") on the announcement of its US$100 million bought deal financing on June 23, 2025.This landmark financing provides the capital needed to advance Vizsla Silver's flagship Panuco Project through final feasibility and into development. With this raise, Vizsla Silver is well-positioned to reach initial product ...

June 24, 2025 8:00 AM EDT | Source: Gorilla Technology Group Inc. London, United Kingdom--(Newsfile Corp. - June 24, 2025) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, has entered into a definitive agreement to acquire CNS, as well as its communication and mobility subsidiary CANS, two of Thailand's most innovative technology solution providers. The transaction ...

Comprehensive Healthcare Systems Secures New York City Based Client on Novus360 for Streamlined, High Value Utilization Management SolutionsJune 24, 2025 7:01 AM EDT | Source: Comprehensive Healthcare Systems Inc.Calgary, Alberta--(Newsfile Corp. - June 24, 2025) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (the "Company" or "CHS"), a leading provider of healthcare benefits administration software and services, is pleased to announce the expansion of its client portfolio with a 5 year r ...

Onyx Gold Continues to Consolidate Key Ground at Munro-Croesus with Strategic Acquisitions June 24, 2025 7:00 AM EDT | Source: Onyx Gold Corp. Total Project Land Holdings Expanded to 109 km2 to cover Key Geological Real Estate Vancouver, British Columbia--(Newsfile Corp. - June 24, 2025) - Onyx Gold Corp. (TSXV: ONYX) (OTCQX: ONXGF) is pleased to announce that it has signed mineral property purchase and sale agreements (the "Purchase Agreements") with two separate arm's length private vendors through its wh ...

June 24, 2025 7:00 AM EDT | Source: InMed Pharmaceuticals Vancouver, British Columbia--(Newsfile Corp. - June 24, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced new preclinical data demonstrating that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation, further supporting its potential a ...

cbdMD Expands Oasis Social Tonics to Total Wine For more information about Oasis Social Tonics, visit www.herbaloasis.com. About Herbal Oasis Herbal Oasis is a premium THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. More information about Oasis Social Tonics can b ...

Toronto, Ontario--(Newsfile Corp. - June 24, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce that our multi-unit franchisee David Lamph has secured his 4th Heal location in Toronto. This new location is located in Cadillac Fairview's Ice Condos at 16 York Street in Toronto. This will mark the second brand within our portfolio to become operational in this high foot-tr ...

Core Insights - Cosmo Pharmaceuticals is set to initiate a groundbreaking clinical usability study in July 2025, evaluating the integration of the GI Genius™ intelligent endoscopy module with Apple Vision Pro at Rush University Medical Center [1][4] - The study aims to assess the real-time application of this innovative technology during live colonoscopy procedures, marking a significant advancement in procedural medicine [2][5] Company Overview - Cosmo Pharmaceuticals N.V. focuses on developing innovative healthcare solutions, particularly in Healthtech/AI, dermatology, and gastroenterology [6][7] - The company has a strategic partnership with Medtronic, which has been the exclusive distributor of the GI Genius™ module since 2019 [5][7] Technology and Innovation - The software application designed for Apple Vision Pro allows physicians to visualize AI-generated insights from the GI Genius™ module without diverting their attention from the operative screen, potentially setting a new standard in GI endoscopy [2][3] - The GI Genius™ system enhances the adenoma detection rate (ADR) of colorectal polyps by up to 14.4%, showcasing its effectiveness in improving diagnostic outcomes [2] Clinical Significance - The upcoming usability study is the first of its kind and will involve patients undergoing routine colonoscopy, contributing to Cosmo's planned FDA submission following the study's conclusion [4] - The integration of AI and spatial computing in this context is expected to revolutionize procedural medicine by embedding real-time AI insights into the physician's workflow [5]